Lemaitre Vascular Stock Performance
| LMAT Stock | USD 87.93 3.49 4.13% |
The company secures a Beta (Market Risk) of 1.27, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LeMaitre Vascular will likely underperform. At this point, LeMaitre Vascular has a negative expected return of -0.15%. Please make sure to verify LeMaitre Vascular's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if LeMaitre Vascular performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LeMaitre Vascular has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 4.13 | Five Day Return 0.0569 | Year To Date Return (3.87) | Ten Year Return 452.67 | All Time Return 1.3 K |
Forward Dividend Yield 0.0091 | Payout Ratio | Forward Dividend Rate 0.8 | Dividend Date 2025-12-04 | Ex Dividend Date 2025-11-20 |
1 | Live market analysis of LeMaitre Vascular Inc. - July 2025 Final Week High Yield Stock Recommendations - Newser | 08/29/2025 |
| LeMaitre Vascular dividend paid on 4th of September 2025 | 09/04/2025 |
2 | Acquisition by George LeMaitre of 21300 shares of LeMaitre Vascular subject to Rule 16b-3 | 09/05/2025 |
3 | New Highs Is LeMaitre Vascular Inc. stock showing strong momentum - Earnings Trend Report Precise Entry and Exit Recommendations - | 09/18/2025 |
4 | When is the best time to exit LeMaitre Vascular Inc. - Risk Management Real-Time Chart Breakout Alerts - newser.com | 10/16/2025 |
5 | LeMaitre Vascular Q3 2025 Earnings Preview | 11/05/2025 |
6 | LeMaitre Reports Sales Below Analyst Estimates In Q3 Earnings | 11/06/2025 |
7 | LMAT Q3 Deep Dive Pricing and Margin Expansion Offset by Cautious Growth Outlook | 11/07/2025 |
8 | Roth Capital Lifts Earnings Estimates for LeMaitre Vascular | 11/11/2025 |
9 | Why LeMaitre Vascular Inc. stock signals breakout potential - Portfolio Performance Report Reliable Intraday Trade Plans - newser.com | 11/13/2025 |
10 | LeMaitre Vascular, Inc. Announces 0.20 Quarterly Dividend | 11/18/2025 |
11 | Disposition of 2681 shares by George LeMaitre of LeMaitre Vascular at 41.02 subject to Rule 16b-3 | 11/20/2025 |
12 | Disposition of 7500 shares by Oconnor John James of LeMaitre Vascular at 37.29 subject to Rule 16b-3 | 11/21/2025 |
| Begin Period Cash Flow | 24.3 M | |
| Total Cashflows From Investing Activities | -200.1 M |
LeMaitre Vascular Relative Risk vs. Return Landscape
If you would invest 9,738 in LeMaitre Vascular on August 25, 2025 and sell it today you would lose (945.00) from holding LeMaitre Vascular or give up 9.7% of portfolio value over 90 days. LeMaitre Vascular is currently does not generate positive expected returns and assumes 1.4866% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than LeMaitre, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LeMaitre Vascular Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LeMaitre Vascular's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LeMaitre Vascular, and traders can use it to determine the average amount a LeMaitre Vascular's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0982
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LMAT |
Estimated Market Risk
| 1.49 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average LeMaitre Vascular is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LeMaitre Vascular by adding LeMaitre Vascular to a well-diversified portfolio.
LeMaitre Vascular Fundamentals Growth
LeMaitre Stock prices reflect investors' perceptions of the future prospects and financial health of LeMaitre Vascular, and LeMaitre Vascular fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LeMaitre Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0794 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 1.84 B | ||||
| Shares Outstanding | 22.69 M | ||||
| Price To Earning | 38.99 X | ||||
| Price To Book | 5.26 X | ||||
| Price To Sales | 8.28 X | ||||
| Revenue | 219.86 M | ||||
| Gross Profit | 170.94 M | ||||
| EBITDA | 66.75 M | ||||
| Net Income | 44.04 M | ||||
| Cash And Equivalents | 75.68 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 185.69 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.34 X | ||||
| Book Value Per Share | 16.71 X | ||||
| Cash Flow From Operations | 44.12 M | ||||
| Earnings Per Share | 2.32 X | ||||
| Market Capitalization | 1.99 B | ||||
| Total Asset | 551.82 M | ||||
| Retained Earnings | 145.09 M | ||||
| Working Capital | 371.58 M | ||||
| Current Asset | 58.18 M | ||||
| Current Liabilities | 10.37 M | ||||
About LeMaitre Vascular Performance
Assessing LeMaitre Vascular's fundamental ratios provides investors with valuable insights into LeMaitre Vascular's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the LeMaitre Vascular is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 296.09 | 205.17 | |
| Return On Tangible Assets | 0.10 | 0.06 | |
| Return On Capital Employed | 0.10 | 0.06 | |
| Return On Assets | 0.08 | 0.04 | |
| Return On Equity | 0.13 | 0.14 |
Things to note about LeMaitre Vascular performance evaluation
Checking the ongoing alerts about LeMaitre Vascular for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LeMaitre Vascular help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LeMaitre Vascular generated a negative expected return over the last 90 days | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Stocks making big moves yesterday Lemonade, Astrana Health, Natures Sunshine, AMC Networks, and Appian |
- Analyzing LeMaitre Vascular's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LeMaitre Vascular's stock is overvalued or undervalued compared to its peers.
- Examining LeMaitre Vascular's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LeMaitre Vascular's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LeMaitre Vascular's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LeMaitre Vascular's stock. These opinions can provide insight into LeMaitre Vascular's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.